Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This molecule is a predicted antisense non-coding RNA transcript located at the INPP4B gene locus (Inositol polyphosphate-4-phosphatase type II B), denoted as LOC124900788 or ENSG00000308479. It is classified as a novel transcript and is not annotated as a canonical protein-coding gene or established therapeutic target. No experimental evidence details its expression, biological function, disease associations, or drug interactions. All information currently refers to its genomic position (antisense to INPP4B), without any functional characterization. Any links to disease or therapy pertain only to the INPP4B coding gene, not to this antisense transcript.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel antisense transcript to Inositol polyphosphate-4-phosphatase type II B (LOC124900788 (no canonical abbreviation established)).